Search for Clinical Trial Results

Sponsored By

Cystadenocarcinoma - 74 Studies Found

Status Study
Active, not recruiting Study Name: Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis
Condition: Noninvasive Mucinous Cystadenocarcinoma of Ovary
Date: 2014-04-22
Interventions: Other: A sampling of blood A sampling of blood de 14 ml
Completed Study Name: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
Condition:
  • Ovarian Clear Cell Cystadenocarcinoma
  • Stage III Ovarian Cancer<
    Date: 2010-09-04
    Interventions:
    • Drug: Carboplatin Given IV
Active, not recruiting Study Name: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
Condition:
  • Borderline Ovarian Surface Epithelial-stromal Tumor
  • Ovarian Serous Cys
    Date: 2007-10-22
    Interventions:
    • Drug: selumetinib Given PO
Terminated Study Name: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm
Condition:
  • Mucinous Cystic Tumor With Moderate Dysplasia
  • Mucinous Cystadenoma of Pancreas
  • Date: 2012-02-01
    Interventions: Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr
Not yet recruiting Study Name: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas
Condition: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC)
Date: 2016-04-22
Interventions:
  • Drug: Birinapant Birinapant -

Recruiting Study Name: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
Condition: HER2/Neu+ Uterine Serous Carcinoma
Date: 2015-07-02
Interventions: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28
Recruiting Study Name: Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
Condition:
  • Ovarian Cancer
  • Ovarian Carcinoma
  • Fallopian Tube Cancer Date: 2017-05-03
    Interventions:
    • Procedure: Uterine lavage Uter
Completed Study Name: Edrecolomab in Treating Patients With Stage II Colon Cancer
Condition:
  • Mucinous Adenocarcinoma of the Colon
  • Signet Ring Adenocarcinoma
    Date: 1999-11-01
    Interventions:
    • Biological: edrecolomab Given

Withdrawn Study Name: Research Study in Patients With Advanced Ovarian Epithelial Cancer
Condition:
  • Ovarian Serous Cystadenocarcinoma
  • Ovarian Serous Surface Papill
    Date: 2003-01-27
    Interventions:
    • Genetic: Comparative Genomic Hybridization

Recruiting Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Condition:
  • Acinar Cell Carcinoma
  • Adrenal Cortex Carcinoma
  • Adrenal Gla
    Date: 2016-07-13
    Interventions:
    • Procedure: Biospecimen Collection

Next >>>